市場調查報告書
商品編碼
1438550
殺幼蟲劑:市場佔有率分析、產業趨勢與統計、成長預測(2024-2029)Larvicides - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024年殺蟲劑市場規模估計為9.5億美元,預計到2029年將達到12.6億美元,在預測期間(2024-2029年)以5.70%的複合年增長率增長。
新型冠狀病毒感染疾病(COVID-19)的突然爆發促使多個國家推出了嚴格的封鎖規定,導致殺幼劑進出口活動受到干擾。疫情期間,地方政府部門和防蚊區將主導大規模滅蚊行動。其中一項活動是散佈幼蟲劑。持有執照的滅蚊專業人員根據受影響區域的大小,使用背包式噴霧器、卡車或飛機使用經環境保護局 (EPA)散佈的殺幼蟲劑。
據世界衛生組織稱,開發中國家40% 的人口面臨感染瘧疾等嚴重的風險。瘧疾是一種危及生命的疾病,由雌性瘧蚊傳播的寄生蟲所引起。例如,2017年,87個國家估計有2.19億例瘧疾病例,瘧疾控制總資金估計為31億美元。熱帶國家的國家捐款達9億美元,佔資金總額的28%。疾病爆發、媒介傳播流行病和害蟲襲擊數量的增加是推動全球殺幼蟲劑市場的一些關鍵因素。其中,由於氣候變遷的影響以及城市害蟲對公眾健康的威脅,亞太地區在殺幼蟲劑市場中佔據較大佔有率。
蚊媒疾病在包括南美洲在內的大多數國家造成了毀滅性的破壞。委內瑞拉報告 2019 年有 126 人死於瘧疾。瘧疾、基屈公病和登革熱等致命疾病可以用殺幼蟲劑治療。例如,茲卡病毒等疾病的爆發使歐洲地區的蚊子數量更加猖獗。撒哈拉以南非洲、中東、拉丁美洲、亞洲和歐洲部分地區是受瘧疾影響的地區。因此,對登革熱和瘧疾病例增加的擔憂為目標地區的殺幼蟲劑市場創造了機會。此外,政府支出和跨國公司在發展中產業的參與正在推動殺幼蟲劑市場的發展。
媒介傳播疾病、傳染病、氣候變遷、害蟲數量增加以及生態學永續性等因素正在推動市場成長。
由於許多跨國公司在該地區的存在,北美估計是最大的消費國。由於有效的監測和病媒控制計劃,美國和加拿大的市場龐大。 2017年,北美佔比最大,其次是歐洲。由於蚊媒疾病的流行,亞太地區預計將維持最高的複合年成長率。高度都市化和公眾對害蟲不容忍的增加預計將加速未來殺幼劑市場的發展。
使用噴霧器將液體殺幼蟲劑產品直接塗布水中。錠劑、丸劑、顆粒劑和木炭塊等殺幼蟲製劑也被繁殖區的滅蚊人員廣泛使用。在美國,美國環保署(美國 EPA)註冊了三種主要類型的幼蟲控制劑:微生物殺幼蟲劑、昆蟲生長抑制劑和化學殺蟲劑(主要是替美磷)。蘇雲金芽孢桿菌(Bti)是一種天然土壤細菌,可以有效殺死水中的蚊子幼蟲。 Aquabac、Teknar、Baltimore 和 Vectobac 是一些市售 Bti 菌株。
殺幼蟲劑市場高度分散。領先公司採用合資、新產品發布、合作、協議、擴張、併購等各種策略來擴大其在市場上的影響力。
The Larvicides Market size is estimated at USD 0.95 billion in 2024, and is expected to reach USD 1.26 billion by 2029, growing at a CAGR of 5.70% during the forecast period (2024-2029).
The sudden outbreak of COVID-19 led to the implementation of stringent lockdown regulations across several nations, resulting in disruptions in the import and export activities of larvicides. Local government departments and mosquito control districts lead large-scale mosquito control activities during an outbreak. One activity is to apply larvicides. Licensed mosquito control professionals apply Environmental Protection Agency (EPA)-registered larvicides using backpack sprayers, trucks, or airplanes, depending on the size of the area being affected.
According to the WHO, 40% of the population living in underdeveloped countries is at risk of serious diseases, such as malaria, which is one of the life-threatening diseases caused by parasites transmitted by female anopheles mosquitoes. For instance, in 2017, there were an estimated 219 million malaria cases in 87 countries, and the total funding for malaria control was estimated at USD 3.1 billion. State contributions from tropical countries contributed to USD 900 million, accounting for 28% of total funding. An increasing number of disease outbreaks, vector-based epidemics, and growing pest attacks are some of the major factors driving the larvicides market globally. Among the regions, Asia-Pacific holds the major share in the larvicides market due to climate change, which poses a threat to public health caused by urban pests.
Mosquito-borne diseases have become devastating in most countries, such as South America. Venezuela reported 126 deaths in 2019 due to malaria. Deadly diseases such as malaria, chikungunya, and dengue can be managed by larvicide. For example, the disease outbreaks such as the Zika virus have made the European region more susceptible to the spread of mosquito populations. Sub-Saharan Africa, the Middle-East, Latin America, Asia, and several parts of Europe are malaria-affected regions. Thus, the concerns about increasing dengue and malaria cases create an opportunity for the larvicides market in the target region. Additionally, government spending in the developing sector and the involvement of multinational companies drive the larvicides market.
Factors such as the increasing prevalence of vector-borne diseases, epidemics, climatic changes, rising pest population, and ecological sustainability are driving the market's growth.
North America is estimated as the largest consumer due to the presence of many multinational companies in the region. The US and Canadian markets are huge due to effective surveillance and vector control programs. North America accounted for the largest share in 2017, followed by Europe. Asia-Pacific is projected to record the highest CAGR due to the spread of mosquito-borne diseases. High urbanization and rising public intolerance of pests are anticipated to fuel the larvicides market in the future.
Liquid larvicide products are applied directly to water using sprayers. Tablet, pellet, granular, and briquet formulations of larvicides are also widely applied by mosquito controllers to breeding areas. In the United States, the Environment Protection Agency (US EPA) registered three major types of larval control agents, i.e., microbial larvicides, insect growth inhibitors, and chemical insecticides (mainly temephos). Bacillus thuringiensis israelensis (Bti) is a naturally occurring soil bacterium that can effectively kill mosquito larvae present in water. Aquabac, Teknar, Baltimore, and Vectobac are some of the commercially available Bti strains.
The larvicides market is highly fragmented. The major players use various strategies such as joint ventures, new product launches, partnerships, agreements, expansions, and mergers and acquisitions to increase their footprint in the market.